Xiao-Yu Lai
Overview
Explore the profile of Xiao-Yu Lai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
61
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guo Q, Liu H, Li L, Jin D, Shi J, Lai X, et al.
World J Radiol
. 2024 Nov;
16(10):600-607.
PMID: 39494132
Background: Post-transplant lymphoproliferative disorder (PTLD) is a rare but highly fatal complication occurring after allogeneic hematopoietic cell transplantation (allo-HCT) or solid organ transplantation (SOT). Unlike SOT, PTLD after allo-HCT usually...
2.
Yuan X, Lai X, Wu Y, Yang L, Shi J, Liu L, et al.
Bone Marrow Transplant
. 2023 Apr;
58(7):801-810.
PMID: 37072477
Relapse remains the leading cause of death in acute myeloid leukemia (AML) patients following allogeneic hematopoietic stem-cell transplantation (allo-HSCT), limiting the efficacy of allo-HSCT. Thus, the ability to identify high-risk...
3.
Ma Y, Wei Z, Xu Y, Shi J, Yi H, Lai Y, et al.
Cancer
. 2023 Mar;
129(13):2013-2022.
PMID: 36951498
Background: Minimal residual disease (MRD) is an important prognostic factor for survival in adults with acute leukemia. The role of pretransplantation MRD status in myelodysplastic syndrome with excess blasts (MDS-EB)...
4.
Yang T, Song X, Zhao Y, Ye B, Luo Y, Xiao H, et al.
Ann Hematol
. 2022 Nov;
101(12):2731-2741.
PMID: 36318288
The use of Bcl-2 inhibitor Venetoclax (VEN) combined with hypomethylating agents or chemotherapy has shown efficacy in treating acute myeloid leukemia (AML) as frontline treatment and for relapse, allowing more...
5.
Yuan X, Tan Y, Shi J, Zhao Y, Yu J, Lai X, et al.
Ann Hematol
. 2020 Oct;
100(2):517-527.
PMID: 33128124
Minimal residual disease (MRD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) heralds high risk of relapse. Whether preemptive recombinant interleukin-2 (pre-IL2) is effective for patients with late-onset MRD (LMRD) remains...
6.
Yang T, Luo X, Yang Q, Chen H, Luo Y, Zhao Y, et al.
Antimicrob Resist Infect Control
. 2020 Mar;
9(1):49.
PMID: 32183898
Background: A consensus has been reached that carbapenem-resistant Enterobacteriaceae (CRE) screening in immunosuppressed individuals can reduce the incidence of CRE bloodstream infection (BSI). Methods: We retrospectively studied the clinical data...
7.
Weng C, Lai X, Zhen C, Dai L, Zhong Z
Zhongguo Zhong Xi Yi Jie He Za Zhi
. 2013 Apr;
33(1):109-13.
PMID: 23596799
Objective: To explore the mechanism of Shangke Jiegu Tablet (SJT)in repairing the mandibular defect. Methods: Totally 72 healthy male New Zealand rabbits were randomly divided into the normal control group...
8.
Wu G, Zhao Y, Huang H, Lai X
Zhejiang Da Xue Xue Bao Yi Xue Ban
. 2011 Oct;
40(5):475-81.
PMID: 21984148
Objective: To investigate the effect of blocking the inhibitory receptors KIR2DL1 and KIR2DL2/2DL3 with monoclonal antibody on cytotoxic activity of human NK cells. Methods: Human peripheral blood NK cells were...
9.
Cao W, Liu L, Lai X, Wang C, Yu X, Huang H
Zhejiang Da Xue Xue Bao Yi Xue Ban
. 2011 Oct;
40(5):467-74.
PMID: 21984147
Objective: To investigate the effects of mycophenolic acid (MPA) on the proliferation and differentiation of human bone marrow-derived mesenchymal stem cells (MSCs). Methods: MSCs were treated with MPA at the...
10.
Jin L, Xiao H, Lai X, Wu G, Luo Y, Shi J, et al.
Zhonghua Nei Ke Za Zhi
. 2010 Jul;
49(4):320-4.
PMID: 20627040
Objective: To explore the relationship between tumor necrosis factor (TNF) gene polymorphisms in donors and recipients and the incidence and severity of acute graft-versus-host diseases (aGVHD) after unrelated allogeneic hematopoietic...